PRF1 and atherosclerosis: Although beyond the scope of this study, the absence of Prf1 during chronic inflammatory diseases such as atherosclerosis may have a considerable impact on any processed/expressed pro-inflammatory cytokinesthat are activated intracellularly by granzymes and could conceivably influence the nature of inflammation(including further granzyme expression) in atherosclerotic plaques further affecting ECM remodelling.